Chromium and genomic stability

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 733, Issue 1-2, 2012, Pages 78-82

  Wise, Sandra S ^a   Wise, John Pierce ^a  

^a UNIVERSITY OF SOUTHERN MAINE   (United States)

Author keywords

Chromate; Chromium; Genomic instability; Hexavalent chromium; Trivalent chromium

Indexed keywords

CHROMIUM; CHROMIUM PICOLINATE;

CARCINOGENICITY; CHEMICAL STRUCTURE; CHROMOSOMAL INSTABILITY; DIET SUPPLEMENTATION; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; GENE MUTATION; GENOMIC INSTABILITY; GENOTOXICITY; HUMAN; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

CARCINOGENS; CHROMIUM; GENOMIC INSTABILITY; HUMANS; NUTRITIVE VALUE;

EID: 84860559105     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2011.12.002     Document Type: Review

References (65)

1. Cahill D.P., Kinzler K.W., Vogelstein B., Lengauer C. Genetic instability and Darwinian selection in tumours. Trends Cell Biol. 1999, 9:M57-M60.
2. Michor F., Iwasa Y., Vogelstein B., Lengauer C., Nowak M.A. Can chromosomal instability initiate tumorigenesis. Semin. Cancer Biol. 2005, 15:43-49.
3. Fenech M., Ferguson L. Vitamins/minerals and genomic stability in humans. Mutat. Res. 2001, 475:1-6.
4. Hartwig A. The role of magnesium in genomic instability. Mutat. Res. 2001, 475:113-121.
5. Linder M. Copper and genomic stability in mammals. Mutat. Res. 2001, 475:141-152.
6. Cheng W-H. Impact of inorganic nutrients on maintenance of genomic stability. Environ. Mol. Mutagen. 2009, 50:349-360.
7. Wise S.S., Holmes A.L., Wise J.P. Hexavalent chromium-induced DNA damage and repair mechanisms. Rev. Environ. Health 2008, 23:39-57.
8. De Flora S., Wetterhahn K.E. Mechanisms of chromium metabolism and genotoxicity. Life Chem. Rep. 1989, 7:169-244.
9. Cohen M.D., Kargacin B., Klein C.B., Costa M. Mechanisms of chromium carcinogenicity and toxicity. Crit. Rev. Toxicol. 1993, 23:255-281.
10. O'Brien T.J., Ceryak S., Patierno S.R. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat. Res. 2003, 533:3-36.
11. Nielson F. The clinical and nutritional importance of chromium - still debated after 50 years of research. The Nutritional Biochemistry of Chromium (III) 2007, 265-276. Elsevier, Amsterdam. J.B. Vincent (Ed.).
12. Vincent J.B., Stallings D. A history of chromium studies (1955-1995). The Nutritional Biochemistry of Chromium (III) 2007, 1-40. Elsevier, Amsterdam. J.B. Vincent (Ed.).
13. Stearns D. Multiple hypotheses for chromium (III) biochemistry: why the essentiality of chromium (III) is still questioned. The Nutritional Biochemistry of Chromium (III) 2007, 57-70. Elsevier, Amsterdam. J.B. Vincent (Ed.).
14. Eastmond D.A., MacGregor J.T., Slesinski R.S. Trivalent chromium: assessing the genotoxic risk of an essential trace element and widely used human and animal nutritional supplement. Crit. Rev. Toxicol. 2008, 38:173-190.
15. Balk E.M., Tatsioni A., Lichtenstein A.H., Lau J., Pittas A.G. Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care 2007, 30:2154-2163.
16. Cefalua W.T., Rooda J., Pinsonata P., Qina J., Seredaa O., Levitana L., Andersonb R.A., Zhanga X.H., Martinc J.M., Martina C.K., Wanga Z.Q., Newcomer B. Characterization of the metabolic and physiologic response from chromium supplementation in subjects with type 2 diabetes. Metabolism 2010, 59:755-762.
17. Gunton J.E., Cheung N.W., Hitchman R., Hams G., O'Sullivan C., Foster-Powell K., McElduff A. Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance. Diabetes Care 2005, 28:712-713.
18. Iqbal N., Cardillo S., Volger S., Bloedon L.T., Anderson R.A., Boston R., Szapary P.O. Chromium picolinate does not improve key features of metabolic syndrome in obese non-diabetic adults. Metab. Syndr. Relat. Disord. 2009, 7:143-150.
19. Snow E. A possible role for chromium (III) in genotoxicity. Environ. Health Perspect. 1991, 92:75-81.
20. Snow E., Xu L. Chromium(III) bound to DNA templates promotes increased polymerase processivity and decreased fidelity during replication in vitro. Biochemistry 1991, 30:11238-11245.
21. Sbrana I., Caretto S., Lascialfari D., Rossi G., Marchi M., Loprieno N. Chromosomal monitoring of chromium-exposed workers. Mutat. Res. 1990, 242:305-312.
22. Medeiros M.G., Rodrigues A.S., Batoreu M.C., Laires A., Rueff J., Zhitkovich A. Elevated levels of DNA-protein crosslinks and micronuclei in peripheral lymphocytes of tannery workers exposed to trivalent chromium. Mutagenesis 2003, 18:19-24.
23. Meibiana Z., Zhijian C., Qing C., Hua Z., Jianlin L., Jiliang H. Investigating DNA damage in tannery workers occupationally exposed to trivalent chromium using comet assay. Mutat. Res. 2008, 654:45-51.
24. Mancuso T.F. Chromium as an industrial carcinogen: Part 1. Am. J. Ind. Med. 1997, 31:129-139.
25. Figgitt M., Newson R., Leslie I.J., Fisher J., Ingham E., Case C.P. The genotoxicity of physiological concentrations of chromium (Cr(III) and Cr(VI)) and cobalt (Co(II)): an in vitro study. Mutat. Res. 2010, 688:53-61.
26. Wise S.S., Wise J.P. Aneuploidy as an early mechanistic event in metal carcinogenesis. Biochem. Soc. Trans. 2010, 38:1650-1654.
27. Holmes A.L., Wise J.P. Mechanisms of metal-induced centrosome amplification. Biochemical Society Transactions 2010, 38:1687-1690.
28. Bagchi D., Stohs S.J., Downs B.W., Bagchi M., Preuss H.G. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 2002, 180:5-22.
29. Andersson M.A., Peterson Grawe K.V., Karlsson O.M., Abramsson-Zetterberg L.A.G., Hellman B.E. Evaluation of the potential genotoxicity of chromium picolinate in mammalian cells in vivo and in vitro. Food Chem. Toxicol. 2007, 45:1097-1106.
30. Stearns D.M., Wise J.P., Patierno S.R., Wetterhahn K.E. Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J. 1995, 9:1643-1648.
31. Stearns D.M., Silveira S.M., Wolf K.K., Luke A.M. Chromium(III) tris(picolinate) is mutagenic at the hypoxanthine (guanine) phosphoribosyltransferase locus in Chinese hamster ovary cells. Mutat. Res. 2002, 513:135-142.
32. Coryell V.H., Stearns D.M. Molecular analysis of hprt mutations induced by chromium picolinate in CHOAA8 cells. Mutat. Res. 2006, 610:114-123.
33. Gudi R., Slesinski R.S., Clarke J.J., San R.H. Chromium picolinate does not produce chromosome damage in CHO cells. Mutat. Res. 2005, 587:140-146.
34. Kareus S.A., Kelley C., Walton H.S., Sinclair P.R. Release of Cr(III) from Cr(III) picolinate upon metabolic activation. J. Hazard. Mater. 2001, 84:163-174.
35. Levina A., Lay P.A Chemical properties and toxicity of chromium(III) nutritional supplements. Chem. Res. Toxicol. 2008, 21:563-571.
36. Stout M.D., Nyska A., Collins B.J., Witt K.L., Kissling G.E., Malarkey D.E., Hooth M.J. Chronic toxicity and carcinogenicity studies of chromium picolinate monohydrate administered in feed to F344/N rats and B6C3F1 mice for 2 years. Food Chem. Toxicol. 2009, 47:729-733.
37. Komorowski J.R., Greenberg D., Juturu V. Chromium picolinate does not produce chromosome damage. Toxicol. In Vitro 2008, 22:819-826.
38. Ke Q., Costa M. Overview of chromium (III) toxicology. The Nutritional Biochemistry of Chromium (III) 2007, 257-263. Elsevier, Amsterdam. J.B. Vincent (Ed.).
39. Zhitkovich A., Song Y., Quievryn G., Voitkun V. Non-oxidative mechanisms are responsible for the induction of mutagenesis by reduction of Cr(VI) with cysteine: role of ternary DNA adducts in Cr(III)-dependent mutagenesis. Biochemistry 2001, 40:549-560.
40. Zhitkovich A., Quievryn G., Messer J., Motylevich Z. Reductive activation with cysteine represents a chromium(III)-dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI). Environ. Health Perspect. 2002, 110:729-731.
41. Quievryn G., Peterson E., Messer J., Zhitkovich A. Genotoxicity and mutagenicity of chromium(VI)/ascorbate-generated DNA adducts in human and bacterial cells. Biochemistry 2003, 42:1062-1070.
42. Quievryn G., Messer J., Zhitkovich A. Lower mutagenicity but higher stability of Cr-DNA adducts formed during gradual chromate activation with ascorbate. Carcinogenesis 2006, 27:2316-2321.
43. Klein C.B., Su L., Bowser D., Leszczynska J. Chromate-induced epimutations in mammalian cells. Environ. Health Perspect. 2002, 110:739-743.
44. Reynolds M., Stoddard L., Bespalov I., Zhitkovich A. Ascorbate acts as a highly potent inducer of chromate mutagenesis and clastogenesis: linkage to DNA breaks in G2 phase by mismatch repair. Nucleic Acids Res. 2007, 35:465-476.
45. Brooks B., O'Brien T.J., Ceryak S., Wise J.P., Wise S.S., Wise J.P., DeFabo E., Patierno S.R. Excision repair is required for genotoxin-induced mutagenesis in mammalian cells. Carcinogenesis 2008, 29:1064-1069.
46. Yavorsky M., Almaden P., King C.G. The vitamin C content of human tissues. J. Biol. Chem. 1934, 106:525-529.
47. Slade R., Stead A.G., Graham J.A., Hatch G.E. Comparison of lung antioxidant levels in humans and laboratory animals. Am. Rev. Respir. Dis. 1985, 131:742-746.
48. Cheng L., Sonntag D.M., de Boer J., Dixon K. Chromium(VI)-induced mutagenesis in the lungs of big blue transgenic mice. J. Environ. Pathol. Toxicol. Oncol. 2000, 19:239-249.
49. Holmes A.L., Wise S.S., Wise J.P. Carcinogenicity of hexavalent chromium. Indian J. Med. Res. 2008, 128:353-372.
50. Hirose T., Kondo K., Takahashi Y., Ishikura H., Fujino H., Tsuyuguchi M., Hashimoto M., Yokose T., Mukai K., Kodama T., Monden Y. Frequent microsatellite instability in lung cancer from chromate-exposed workers. Mol. Carcin. 2002, 33:172-180.
51. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Chromium, Nickel and Welding, vol. 49, International Agency for Research on Cancer, Lyons, France, 1990.
52. Leonard A., Lauwerys R.R. Carcinogenicity and mutagenicity of chromium. Mutat. Res. 1980, 76:227-239.
53. Levy L.S., Vanitt S. Carcinogenicity and mutagenicity of chromium compounds: the association between bronchial metaplasia and neoplasia. Carcinogenesis 1986, 7:831-835.
54. Patierno S.R., Banh D., Landolph J.R. Transformation of C3H/10T1/2 mouse embryo cells by insoluble lead chromate but not soluble calcium chromate: relationship to mutagenesis and internalization of lead chromate particles. Cancer Res. 1988, 47:3815-3823.
55. Langard S. One hundred years of chromium and cancer: a review of epidemiological evidence and selected case reports. Am. J. Ind. Med. 1990, 17:189-215.
56. Xie H., Holmes A.L., Wise S.S., Huang S., Peng C., Wise J.P. Neoplastic transformation of human bronchial cells by lead chromate particles. Am. J. Respir. Cell. Mol. Biol. 2007, 37:544-552.
57. Xie H., Wise S.S., Wise J.P. Deficient repair of particulate chromate-induced DNA double strand breaks leads to neoplastic transformation. Mutat. Res. 2008, 649:230-238.
58. Holmes A.L., Wise S.S., Sandwick S.J., Lingle W.L., Negron V.C., Thompson W.D., Wise J.P. Chronic exposure to lead chromate causes centrosome abnormalities and aneuploidy in human lung cells. Cancer Res. 2006, 66:4041-4048.
59. Wise S.S., Holmes A.L., Xie H., Thompson W.D., Wise J.P. Chronic exposure to particulate chromate induces spindle assembly checkpoint bypass in human lung cells. Chem. Res. Toxicol. 2006, 19:1492-1498.
60. Dunstan E., Ladon D., Whittingham-Jones P., Carrington R., Briggs T.W.R. Chromosomal aberrations in the peripheral blood of patients with metal-on-metal hip bearings. J. Bone Joint Surg. 2008, 90-A:517-522.
61. Collins B.J., Stout M.D., Levine K.E., Kissling G.E., Melnick R.L., Fennell T.R., Walden R., Abdo K., Pritchard J.B., Fernando R.A., Burka L.T., Hooth M.J. Exposure to hexavalent chromium resulted in significantly higher tissue chromium burden compared to trivalent chromium following similar oral doses to male F344/n rats and female B6C3F1 mice. Toxicol. Sci. 2010, 118:368-379.
62. National Toxicology Program (NTP), Toxicology and Carcinogenesis Studies of Sodium Dichromate Dihydrate (CAS No. 7789-12-0) in F344/N Rats and B6C3F1 Mice Drinking Water Studies, National Toxicology Program, Research Triangle Park, NC, 2008.
63. Stout M.D., Herbert R.A., Kissling G.E., Collins B.J., Travlos G.S., Witt K.L., Melnick R.L., Abdo K.M., Malarkey D.E., Hooth M.J. Hexavalent chromium is carcinogenic to F344/N rats and B6C3F1 mice after chronic oral exposure. Environ. Health Perspect. 2009, 117:716-722.
64. Linos A., Petralias A., Christophi C.A., Christoforidou E., Kouroutou P., Stoltidis M., Veloudaki A., Tzala E., Makris K.C., Karagas M.R. Oral ingestion of hexavalent chromium through drinking water and cancer mortality in an industrial area of Greece - an ecological study. Environ. Health 2011, 10. 10.1186/1476-069X-10-50.
65. Thompson C.M., Haws L.C., Harris M.A., Gatto N.M., Proctor D.M. Application of the U.S. EPA mode of action framework for purposes of guiding future research: a case study involving the oral carcinogenicity of hexavalent chromium. Toxicol. Sci. 2011, 119:20-40.